BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38679356)

  • 1. Malignancy Risk Associated With the Use of Systemic Immunomodulatory Therapy in the Management of Noninfectious Uveitis.
    Papaliodis GN; Yu Y; Brill DA; Sobrin L; VanderBeek B
    Am J Ophthalmol; 2024 Apr; 265():241-247. PubMed ID: 38679356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Association between Noninfectious Uveitis and Coronavirus Disease 2019 Outcomes: An Analysis of United States Claims-Based Data.
    Miller DC; Sun Y; Chen EM; Arnold BF; Acharya NR
    Ophthalmology; 2022 Mar; 129(3):334-343. PubMed ID: 34648828
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics of non-infectious uveitis treated with and without systemic immunomodulatory therapy.
    Felfeli T; Eshtiaghi A; Rhee J; Balas M; Tai F; Kaplan AJ; Christakis PG; Dzulynsky K; Monson H; Mandelcorn ED; Rubin LA; Bakshi NK; Derzko-Dzulynsky LA
    Can J Ophthalmol; 2023 Nov; ():. PubMed ID: 37972648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of COVID-19 pandemic on uveitis patients receiving immunomodulatory and biological therapies (COPE STUDY).
    Agarwal AK; Sudharshan S; Mahendradas P; Babu K; Shenoy P; Dogra M; Bansal R; Agarwal M; Biswas J; Balamurugan S; Agrawal R; Gupta V
    Br J Ophthalmol; 2022 Jan; 106(1):97-101. PubMed ID: 33011688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Noninfectious Uveitis in the United States: A Claims-Based Analysis.
    Thorne JE; Suhler E; Skup M; Tari S; Macaulay D; Chao J; Ganguli A
    JAMA Ophthalmol; 2016 Nov; 134(11):1237-1245. PubMed ID: 27608193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of Noninfectious Uveitis after Coronavirus Disease 2019 Vaccination in a United States Claims Database.
    Kumar A; Miller DC; Sun Y; Arnold BF; Acharya NR
    Ophthalmology; 2023 Dec; 130(12):1269-1278. PubMed ID: 37480943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between Immunosuppressive Drugs and Coronavirus Disease 2019 Outcomes in Patients with Noninfectious Uveitis in a Large US Claims Database.
    Sun Y; Miller DC; Akpandak I; Chen EM; Arnold BF; Acharya NR
    Ophthalmology; 2022 Oct; 129(10):1096-1106. PubMed ID: 35588945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of systemic corticosteroids in patients newly registered at a claims database with a diagnosis of non-infectious uveitis: results from a real-world claims database analysis.
    Umazume A; Ohguro N; Okada AA; Namba K; Sonoda KH; Tsuruga H; Morita K; Goto H
    Jpn J Ophthalmol; 2022 Jul; 66(4):394-404. PubMed ID: 35670922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Dimensional Profiling Reveals Heterogeneity of the Th17 Subset and Its Association With Systemic Immunomodulatory Treatment in Non-infectious Uveitis.
    Verhagen FH; Hiddingh S; Rijken R; Pandit A; Leijten E; Olde Nordkamp M; Ten Dam-van Loon NH; Nierkens S; Imhof SM; de Boer JH; Radstake TRDJ; Kuiper JJW
    Front Immunol; 2018; 9():2519. PubMed ID: 30429855
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of Multidrug Resistance Proteins in Nonresponders to Immunomodulatory Therapy for Noninfectious Uveitis.
    Tagirasa R; Rana K; Kaza H; Parai D; Damera S; Basu S
    Transl Vis Sci Technol; 2020 Apr; 9(5):12. PubMed ID: 32821484
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local versus Systemic Therapy for Noninfectious Uveitis (NIU).
    Chang EL; Sobrin L
    Semin Ophthalmol; 2023 Jan; 38(1):15-23. PubMed ID: 36471661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcomes of noninfectious uveitis treated with systemic immunomodulatory therapy: a retrospective case series.
    Felfeli T; Balas M; Tai F; Eshtiaghi A; Rhee J; Kaplan AJ; Christakis PG; Mandelcorn ED; Bakshi NK; Rubin LA; Derzko-Dzulynsky LA
    Can J Ophthalmol; 2024 Jun; ():. PubMed ID: 38889882
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologics for the treatment of noninfectious uveitis: current concepts and emerging therapeutics.
    Thomas AS
    Curr Opin Ophthalmol; 2019 May; 30(3):138-150. PubMed ID: 30844945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased risk of non-infectious anterior uveitis with statin therapy in a large healthcare claims database.
    Sobrin L; Yu Y; Han S; Susarla G; Kempen JH; Hubbard RA; VanderBeek BL
    Graefes Arch Clin Exp Ophthalmol; 2021 Sep; 259(9):2783-2793. PubMed ID: 34050812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic.
    Agrawal R; Testi I; Lee CS; Tsui E; Blazes M; Thorne JE; Okada AA; Smith JR; McCluskey PJ; Kempen JH; Tappeiner C; Agarwal M; Bodaghi B; Nguyen QD; Gupta V; De Smet MD; Zierhut M; Pavesio C;
    Br J Ophthalmol; 2021 May; 105(5):639-647. PubMed ID: 32586933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunosuppressive Medications and COVID-19 Outcomes in Patients with Noninfectious Uveitis in the Era of COVID-19 Vaccinations.
    Sechrist SJ; Tang E; Sun Y; Arnold BF; Acharya NR
    Ophthalmol Sci; 2024; 4(2):100411. PubMed ID: 38146526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Network of Serum Proteins Predict the Need for Systemic Immunomodulatory Therapy at Diagnosis in Noninfectious Uveitis.
    Kuiper JJW; Verhagen FH; Hiddingh S; Wennink RAW; Hansen AM; Casey KA; Hoefer IE; Haitjema S; Drylewicz J; Yakin M; Sen HN; Radstake TRDJ; de Boer JH
    Ophthalmol Sci; 2022 Sep; 2(3):100175. PubMed ID: 36245752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T cells and IL-17A levels in noninfectious uveitis.
    Guedes MCE; Arroz MJ; Martins C; Angelo-Dias M; Proença RD; Borrego LM
    Graefes Arch Clin Exp Ophthalmol; 2020 Jun; 258(6):1269-1278. PubMed ID: 32200408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignancy risk in patients with inflammatory eye disease treated with systemic immunosuppressive therapy: a tertiary referral cohort study.
    Yates WB; Vajdic CM; Na R; McCluskey PJ; Wakefield D
    Ophthalmology; 2015 Feb; 122(2):265-73. PubMed ID: 25312044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Real-world evidence of treatment for relapse of noninfectious uveitis in tertiary centers in Japan: A multicenter study.
    Takeuchi M; Kanda T; Kaburaki T; Tanaka R; Namba K; Kamoi K; Maruyama K; Shibuya E; Mizuki N
    Medicine (Baltimore); 2019 Mar; 98(9):e14668. PubMed ID: 30817592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.